Robert Hart

Robert S. Hart

Director, Disease Modeling

Robert S. Hart serves as the director of the Disease Modeling team and vice president and general manager of the Institute for Disease Modeling (IDM). He leads the team that builds innovative data analysis tools to facilitate eradication of infectious disease by the global health community.

Robert has over thirty years of experience founding and managing high technology-based software firms as an executive officer and venture investor, as well as serving as a board director. Prior to joining IDM, he served as a founder and the CEO of Veratect Corporation, an open source data mining and analysis firm providing the earliest possible indicators of the emergence of infectious disease worldwide, but with a particular focus on the developing world. Prior to Veratect, highlights of Robert’s career include tenure as the CEO of Corazonx, a cardiac ultrasound software firm; general partner at SeaPoint Ventures, a venture capital firm focusing on the wireless telecom industry; CEO of Tegic Communications, the developer of the predictive text input software used in most cellular phones; CEO of Optimas Corporation, a digital image analysis firm; and founder and CEO of Sierra Geophysics, a leading provider of applications software to the global oil and gas industry. He currently serves on a number of corporate and non-profit boards.

Robert has a Ph.D. in Geophysics as well as a Master of Science degree in Geophysics from the California Institute of Technology (CalTech), and a Bachelor of Science degree in Earth and Planetary Sciences from the Massachusetts Institute of Technology (MIT).

More about the foundation

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education.


Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.